3 results match your criteria: "Reproductive Medicine Center of Zibo Maternity and Child Health Hospital[Affiliation]"
Reprod Biol
June 2021
Reproductive Medicine Center of Zibo Maternity and Child Health Hospital, Zibo, 255000, PR China. Electronic address:
The aim of this article was to assess whether and how BARX1 affects the progression of malignant phenotype of endometrial carcinoma (EC) cells. BARX1 levels and its prognostic value were evaluated using the EC-related RNA sequence dataset from The Cancer Genome Atlas (TCGA) database. Functional experiments were performed to evaluate the biological roles of BARX1 in EC HEC-1-A and KLE cells by silencing BARX1.
View Article and Find Full Text PDFAnat Rec (Hoboken)
March 2021
Department of Pharmacy, Reproductive Medicine Center of Zibo Maternity and Child Health Hospital, Zibo, China.
Penfluridol, a commonly used antipsychotic agent in a clinical setting, exhibits potential anticancer properties against various human malignancies. Here, we investigated the effect of penfluridol on the biological behavior of colorectal cancer (CRC) cells. Cell viability and clonogenic potential were detected by the cell counting kit-8 and colony formation assay.
View Article and Find Full Text PDFPrenat Diagn
March 2019
Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Objective: To detect APELA gene variants in clinical cases with preeclampsia (PE) and evaluate the influence of the APELA variants in gene expression.
Method: A total of 288 individuals suffering from PE and 384 unaffected individuals were chosen for case-control studies. Genomic DNA was extracted from peripheral blood.